Rydex Energy Services Fund Class H
RYVAX
NASDAQ
| Weiss Ratings | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Rydex Funds | |||
| Manager/Tenure (Years) | Michael P. Byrum (26), Adrian Bachman (2), Brendan Cain (2), 2 others | |||
| Website | http://www.guggenheiminvestments.com | |||
| Fund Information | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Rydex Energy Services Fund Class H | |||
| Category | Equity Energy | |||
| Sub-Category | Energy Sector Equity | |||
| Prospectus Objective | Specialty - Natural Resources | |||
| Inception Date | Apr 02, 1998 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 3.33% | |||
| Asset Allocation | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.49% | |||
| Stock | 99.79% | |||
| U.S. Stock | 94.73% | |||
| Non-U.S. Stock | 5.06% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | -1.29% | |||
| Price History | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.50% | |||
| 30-Day Total Return | -10.14% | |||
| 60-Day Total Return | -16.94% | |||
| 90-Day Total Return | -5.11% | |||
| Year to Date Total Return | -8.96% | |||
| 1-Year Total Return | -21.59% | |||
| 2-Year Total Return | 3.57% | |||
| 3-Year Total Return | -7.31% | |||
| 5-Year Total Return | 187.57% | |||
| Price | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $184.92 | |||
| 1-Month Low NAV | $176.79 | |||
| 1-Month High NAV | $205.78 | |||
| 52-Week Low NAV | $176.79 | |||
| 52-Week Low NAV (Date) | Mar 13, 2025 | |||
| 52-Week High NAV | $249.24 | |||
| 52-Week High Price (Date) | Apr 05, 2024 | |||
| Beta / Standard Deviation | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.29 | |||
| Standard Deviation | 37.01 | |||
| Balance Sheet | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 6.09M | |||
| Operating Ratios | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.65% | |||
| Turnover Ratio | 296.00% | |||
| Performance | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -2.60% | |||
| Last Bear Market Total Return | -19.81% | |||
